Loading...
XASX
SHL
Market cap6.85bUSD
Sep 17, Last price  
19.62AUD
1D
0.41%
1Q
-2.14%
Jan 2017
-8.32%
Name

Sonic Healthcare Ltd

Chart & performance

D1W1MN
XASX:SHL chart
P/E
15.94
P/S
0.89
EPS
1.23
Div yield, %
7.73%
Shrs. gr., 5y
0.54%
Rev. gr., 5y
4.58%
Revenues
10.95b
+13.52%
1,846,843,0002,331,425,0002,968,992,0002,972,613,0003,082,883,0003,322,532,0003,425,112,0003,854,989,0004,141,094,0004,947,307,0005,053,724,0005,476,175,0006,133,671,0006,562,590,0008,752,536,0009,306,543,0008,144,998,0008,934,198,0009,645,448,00010,949,838,000
Net income
608m
+18.44%
198,072,000245,116,000171,360,000293,225,000294,535,000315,996,000334,998,000384,984,000347,698,000451,374,000427,773,000475,606,000549,725,000527,749,0001,315,040,0001,460,566,000684,984,000511,094,000513,597,000608,293,000
CFO
1.41b
+8.38%
267,935,000331,885,000429,952,000429,497,000409,019,000486,758,000459,459,000556,358,000512,084,000707,708,000736,365,000767,920,000847,308,0001,360,298,0002,042,836,0002,225,821,0001,471,033,0001,071,512,0001,296,790,0001,405,451,000
Dividend
Sep 02, 20260.63 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Sydney, Australia, in 1934, Sonic Healthcare Limited is a prominent international provider of extensive medical diagnostic services. The company caters to a wide array of clients, including individual medical practitioners, hospitals, community health organizations, and, by extension, their patients. Sonic Healthcare's core operations are divided into three main service categories: 1. Laboratory Medicine/Pathology: This segment offers a broad spectrum of diagnostic testing, encompassing biochemistry, cytopathology (cell analysis), genetic screening, haematology (blood analysis), histopathology (tissue examination), immunoserology (immune system testing), microbiology (infectious disease detection), molecular pathology, prenatal testing, and toxicology, alongside various supporting laboratory functions. 2. Radiology Services: The company provides advanced medical imaging, which includes magnetic resonance imaging (MRI), computed tomography (CT) scans, ultrasound, X-ray, mammography, nuclear medicine, PET CT scans, interventional procedures, and bone mineral densitometry for assessing bone density. 3. Primary Care Medical Services: Sonic Healthcare also delivers a range of general practice and community health solutions. These comprise general practitioner clinics, occupational health support, specialized clinics for skin cancer, after-hours GP services, IT solutions designed for general practices, and other community-based healthcare initiatives. With a substantial global presence, Sonic Healthcare Limited conducts its operations across Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and other international regions.

Related entities

Subsidiaries (4)
Sonic Healthcare Holding Company
Sonic Healthcare Services Pty Limited
SH Euro Finance PLC
The Doctors Laboratory Limited

Key people

Philip J. Dubois
Executive Director · since 2001
Colin S. Goldschmidt
Chief Executive Officer, Managing Director, Executive Director · since 2014
Paul J. Alexander
Deputy Chief Financial Officer, Company Secretary · since 2013
Mark Raymond Compton
Non-Executive Independent Chairman of the Board · since 2015
Suzanne Crowe
Non-Executive Independent Director · since 2020
Non-Executive Independent Director · since 2005
Non-Executive Independent Director · since 2010
Elizabeth Jane Wilson
Non-Executive Independent Director · since 2010
IPO date
Sep 25, 1934
Employees
41,000
Domiciled in
AU
Incorporated in
AU
Headquarters & legal address
Level 22
Grosvenor Place
225 George Street
Sydney, NSW 2000
AU
Previous name
Gunnersen Nosworth Limited
Previous name
Gunnersen Nosworthy Proprietary Limited
Previous name
Sonic Technology Australia Limited

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT